Some returns feel commercial. This one feels personal.Celine Dion’s announcement that she will return to the stage with 10 concerts in Paris this fall...

In biotech, not every approval changes the mood around a product. This one might.The FDA’s approval of a higher-dose version of Biogen’s Spinraza is...

Drug companies talk about pipelines all the time. Investors hear it, analysts hear it, and patients hear it. Most of the time, it sounds...

For a few brief days, markets tried to believe that diplomacy might buy time, calm nerves, and reopen the path to stability. That illusion...